- Home
- SUPN vs HBI Comparison
SUPN vs HBI Comparison
Compare SUPN & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- HBI
- Stock Information
- Founded
- SUPN 2005
- HBI 1901
- Country
- SUPN United States
- HBI United States
- Employees
- SUPN N/A
- HBI N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- HBI Clothing/Shoe/Accessory Stores
- Sector
- SUPN Health Care
- HBI Consumer Discretionary
- Exchange
- SUPN Nasdaq
- HBI Nasdaq
- Market Cap
- SUPN 1.9B
- HBI 1.9B
- IPO Year
- SUPN 2012
- HBI 2006
- Fundamental
- Price
- SUPN $32.28
- HBI $4.43
- Analyst Decision
- SUPN Hold
- HBI Hold
- Analyst Count
- SUPN 2
- HBI 4
- Target Price
- SUPN $36.00
- HBI $5.75
- AVG Volume (30 Days)
- SUPN 529.3K
- HBI 4.2M
- Earning Date
- SUPN 08-05-2025
- HBI 08-07-2025
- Dividend Yield
- SUPN N/A
- HBI N/A
- EPS Growth
- SUPN N/A
- HBI N/A
- EPS
- SUPN 1.11
- HBI N/A
- Revenue
- SUPN $667,997,000.00
- HBI $3,522,911,000.00
- Revenue This Year
- SUPN N/A
- HBI $0.50
- Revenue Next Year
- SUPN $12.02
- HBI N/A
- P/E Ratio
- SUPN $29.32
- HBI N/A
- Revenue Growth
- SUPN 11.82
- HBI 0.65
- 52 Week Low
- SUPN $25.55
- HBI $4.02
- 52 Week High
- SUPN $40.28
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- SUPN 48.28
- HBI 33.78
- Support Level
- SUPN $31.56
- HBI $4.54
- Resistance Level
- SUPN $33.15
- HBI $4.71
- Average True Range (ATR)
- SUPN 0.92
- HBI 0.13
- MACD
- SUPN -0.03
- HBI -0.05
- Stochastic Oscillator
- SUPN 40.34
- HBI 5.63
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.